June 12, 2017June 12, 2017
Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and ... Read more
June 7, 2017June 7, 2017
Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, ... Read more
June 5, 2017June 5, 2017
EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for the review of biosimilars for AbbVie’s Humira (adalimumab) and Janssen’s Remicade ... Read more
June 2, 2017June 2, 2017
DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less ... Read more
May 23, 2017May 23, 2017
Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid ... Read more

May 10, 2017May 10, 2017

Phase 3 Trial Finds Kevzara Superior to Humira, and Just as Safe, in Treating Rheumatoid Arthritis

The drug Kevzara (sarilumab) is more effective than Humira (adalimumab) — and just as safe — in treating rheumatoid arthritis (RA) in patients who cannot tolerate or don’t respond ... Read more

May 8, 2017May 10, 2017

Despite Treatment, 80% of RA Patients Report ‘Life-Altering’ Pain Weekly or Even Daily, Survey Finds

News

Honestly RA, an online survey for Americans with rheumatoid arthritis (RA), found that although most RA patients agree that the treatments improve their lives, 80 percent still experience life-altering pain multiple ... Read more

May 5, 2017May 5, 2017

Kevzara Takes Step Toward EU Approval, While FDA Decision Is Expected in May

News, rheumatoid arthritis

Kevzara (sarilumab) has received a thumbs-up from the European Medicine Agency (EMA), which has recommended that the European Commission approve it to treat adults with moderate to severe rheumatoid arthritis, ... Read more

May 3, 2017May 3, 2017

Rheumatoid Arthritis Patients More Likely to Develop Atherosclerosis, British Study Shows

News, rheumatoid arthritis

People with rheumatoid arthritis (RA) are more likely to develop atherosclerosis, a chronic inflammatory condition affecting the heart, according to new research. The study, “Imaging atherosclerosis in rheumatoid arthritis: evidence ... Read more

April 28, 2017April 28, 2017

Phase 3 Trial of Can-Fite’s Piclidenoson for Treating RA Is Underway

News

Can-Fite BioPharma’s Phase 3 ACRobat clinical trial protocol was approved by Barzilai Medical Center’s Institutional Review Board (IRB) and patient enrollment is now ready to begin. The study will ... Read more

April 26, 2017April 26, 2017

Researchers Find 2 Potential Molecules for Fighting Rheumatoid Arthritis, Other Inflammatory Diseases

News, rheumatoid arthritis

Greek researchers have found two molecules — T23 and T8 — that show promise in treating rheumatoid arthritis and other chronic inflammatory diseases. Both molecules act against tumor necrosis ... Read more

April 24, 2017April 24, 2017

Early Treatment Improves Rheumatoid Arthritis Symptoms, Helps Patients Live Longer, Study Suggests

News, rheumatoid arthritis

Earlier and more aggressive treatment of rheumatoid arthritis (RA) helps patients grip things, walk and dress themselves better — and live longer, a study suggests. The daily lives of ... Read more

April 19, 2017April 19, 2017

Inmedix, Omegawave to Adapt Elite-athlete Tests to Rheumatoid Arthritis Diagnosis

News, rheumatoid arthritis

Inmedix and Omegawave will work together on medical applications of tests related to athletes’ performance, with one target being rheumatoid arthritis (RA). A key goal will be to enhance biomarker ... Read more

April 17, 2017April 19, 2017

FDA Asks More Information a Second Time on Baricitinib as Arthritis Therapy

News, rheumatoid arthritis

U.S. regulators want additional dosing- and safety-related information before they will approve Eli Lilly and Incyte‘s New Drug Application (NDA) request for the rheumatoid arthritis (RA) treatment baricitinib. It is the ... Read more

April 12, 2017April 12, 2017

Obesity May Alter Diagnosis, Management of RA When Blood Tests Are Used

News, rheumatoid arthritis

Obesity in women may interfere with the diagnosis and monitoring of rheumatoid arthritis (RA) through blood tests, according to a new study. Researchers call for more attention to the ... Read more